What is EOS Surfaces?
EOS Surfaces provides an innovative, EPA-registered copper-infused solid surface that actively and continuously kills bacteria, thereby reducing hospital-acquired infections (HAIs) without requiring additional cleaning protocols. Their advanced material is primarily targeted towards healthcare facilities, government installations, and design professionals seeking to integrate superior infection prevention technologies into their projects. By collaborating with architects, designers, and fabricators, EOS Surfaces aims to deploy solutions that can potentially save lives and mitigate healthcare costs, with a particular focus on supporting veteran healthcare systems.
How much funding has EOS Surfaces raised?
EOS Surfaces has raised a total of $10.2M across 2 funding rounds:
Debt
$9.9M
Debt
$350K
Debt (2014): $9.9M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in EOS Surfaces
PPP
Public-Private Partnership
What's next for EOS Surfaces?
The recent major strategic investment, structured as debt financing, suggests EOS Surfaces is in a phase of scaling its operations and market penetration. This capital infusion is likely to support the expansion of manufacturing capabilities, further research and development into antimicrobial surface technologies, and broader market outreach, particularly within the government and healthcare sectors. The company's focus on reducing HAIs positions it to capitalize on increasing demands for safer, more hygienic environments, especially in the wake of heightened global health awareness. Continued strategic partnerships and product development will be key to solidifying its market leadership in infection prevention surfaces.
See full EOS Surfaces company page
